» Articles » PMID: 30300146

Gleason Grading: Clear and Straightforward Rules Facilitate Judgment

Overview
Date 2018 Oct 10
PMID 30300146
Citations 1
Authors
Affiliations
Soon will be listed here.
Citing Articles

Clinical analysis of EV-Fingerprint to predict grade group 3 and above prostate cancer and avoid prostate biopsy.

Fairey A, Paproski R, Pink D, Sosnowski D, Vasquez C, Donnelly B Cancer Med. 2023; 12(15):15797-15808.

PMID: 37329212 PMC: 10469644. DOI: 10.1002/cam4.6216.